Skip to main content
Premium Trial:

Request an Annual Quote

Epocal, Procognia, Sense Proteomic, Abbott Laboratories, Luminex, Purdue University, Roche Diagnostics

Premium

Canadian Microarray Firm Gets VC Nod, Again

Epocal of Ottawa received CA $3.1 ($2.0) million in early-stage venture capital funding from Genesys Capital Partners. Genesys was the sole investor in the latest round, drawing funds from the New Generation Biotech Equity Fund, a labor-sponsored fund administered by Toronto-based Triax-Covington. The firm now has some $6.5 million invested in Epocal.

Epocal, founded by I-Stat founder Imants Lauks in 2001, develops sensor microarrays with fluidic circuits for DNA, cell, and protein assays targeting the genomic, diagnostic, and drug development markets.

 

Procognia Acquires Sense Proteomic

Procognia of Maidenhead, UK, has acquired protein chip manufacturer Sense Proteomic of Cambridge, UK, the companies announced. Financial details were not available.

Sense Proteomic’s staff will be integrated into Procognia and will remain at the Babraham Institute in Cambridge for at least another six months, according to a statement.

Procognia, which now has 60 employees, has developed technologies for the analysis of glycosylation patterns on proteins, which will be complemented by Sense’s functional array technology, the company said.

Procognia also said it closed a $4 million financing round from Apax Partners, Evergreen Partners, and Vitalife, bringing its total funding since its founding in April 2002 to $18.3 million.

 

Abbott Licenses Luminex Technology

Abbott Laboratories has entered two agreements for license, supply, and distribution rights to Luminex technology, Luminex said last week. Under the license agreement, Abbott will pay Luminex an upfront, non-refundable, license fee and royalties on commercialized assays and instruments. The related supply agreement covers the terms under which Abbott will purchase Luminex 100 systems and xMAP microspheres. Financial details were not disclosed.

 

Life Sciences Business Plan Competition

The Burton D. Morgan Center for Entrepreneurship at Purdue University and Roche Diagnostics are hosting a competition for life sciences business plans. Groups from academia, early-stage businesses, and established firms can compete for $100,000 in prize money and face-time with funders. Judging of eight finalists will be conducted on April 23 at Purdue.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.